US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 9.850
  • -0.020-0.20%
Trading Feb 27 11:45 ET
998.34MMarket Cap-9.66P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
131.16M
29.21M
93.76M
8.19M
0
0
0
0
0
0
Operating revenue
--131.16M
--29.21M
--93.76M
--8.19M
--0
--0
--0
--0
--0
--0
Cost of revenue
5.28M
2.98M
1.59M
707K
0
0
0
0
Gross profit
125.88M
26.23M
92.17M
7.49M
0
0
0
0
Operating expense
66.53%343.15M
53.84%91.56M
21.57%62.54M
148.29%122.29M
45.60%66.77M
40.27%206.06M
39.24%59.52M
29.57%51.44M
34.14%49.25M
65.26%45.86M
Selling and administrative expenses
52.83%115.45M
34.13%29.74M
58.53%28.97M
76.82%30.19M
47.32%26.56M
23.25%75.54M
32.57%22.17M
3.46%18.28M
20.57%17.07M
41.44%18.03M
-General and administrative expense
----
----
----
----
47.32%26.56M
----
----
----
----
41.44%18.03M
Research and development costs
74.46%227.7M
65.53%61.82M
1.21%33.56M
186.20%92.11M
44.49%40.21M
52.45%130.52M
43.54%37.35M
50.50%33.16M
42.65%32.18M
85.48%27.83M
Operating profit
-5.44%-217.27M
-9.77%-65.33M
157.61%29.64M
-133.09%-114.81M
-45.60%-66.77M
-40.27%-206.06M
-39.24%-59.52M
-29.57%-51.44M
-34.14%-49.25M
-65.26%-45.86M
Net non-operating interest income expense
Other net income (expense)
651.84%128.92M
21.69%6.09M
23.28%6.52M
3,201.45%111.95M
25.79%4.36M
262.67%17.15M
90.05%5.01M
177.73%5.29M
1,694.18%3.39M
346,100.00%3.46M
Gain on sale of security
14.63%19.7M
20.46%6.05M
0.59%5.32M
16.32%3.96M
25.94%4.37M
262.14%17.19M
88.87%5.02M
179.21%5.29M
1,702.12%3.41M
173,200.00%3.47M
Other non- operating income (expenses)
273,142.50%109.22M
322.22%40K
40,000.00%1.2M
720,033.33%107.99M
-150.00%-10K
-122.22%-40K
30.77%-18K
-133.33%-3K
---15K
-300.00%-4K
Income before tax
53.23%-88.35M
-8.68%-59.24M
178.34%36.16M
93.77%-2.86M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
Income tax
7.14M
6.47M
-882K
1.55M
0
0
0
0
Net income
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
Net income continuous Operations
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
Minority interest income
Net income attributable to the parent company
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
Basic earnings per share
56.96%-1.02
-7.81%-0.69
170.37%0.38
91.80%-0.05
-22.03%-0.72
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
Diluted earnings per share
56.96%-1.02
-7.81%-0.69
170.37%0.38
91.80%-0.05
-22.03%-0.72
-9.22%-2.37
-14.29%-0.64
-1.89%-0.54
-1.67%-0.61
-22.92%-0.59
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 131.16M29.21M93.76M8.19M000000
Operating revenue --131.16M--29.21M--93.76M--8.19M--0--0--0--0--0--0
Cost of revenue 5.28M2.98M1.59M707K0000
Gross profit 125.88M26.23M92.17M7.49M0000
Operating expense 66.53%343.15M53.84%91.56M21.57%62.54M148.29%122.29M45.60%66.77M40.27%206.06M39.24%59.52M29.57%51.44M34.14%49.25M65.26%45.86M
Selling and administrative expenses 52.83%115.45M34.13%29.74M58.53%28.97M76.82%30.19M47.32%26.56M23.25%75.54M32.57%22.17M3.46%18.28M20.57%17.07M41.44%18.03M
-General and administrative expense ----------------47.32%26.56M----------------41.44%18.03M
Research and development costs 74.46%227.7M65.53%61.82M1.21%33.56M186.20%92.11M44.49%40.21M52.45%130.52M43.54%37.35M50.50%33.16M42.65%32.18M85.48%27.83M
Operating profit -5.44%-217.27M-9.77%-65.33M157.61%29.64M-133.09%-114.81M-45.60%-66.77M-40.27%-206.06M-39.24%-59.52M-29.57%-51.44M-34.14%-49.25M-65.26%-45.86M
Net non-operating interest income expense
Other net income (expense) 651.84%128.92M21.69%6.09M23.28%6.52M3,201.45%111.95M25.79%4.36M262.67%17.15M90.05%5.01M177.73%5.29M1,694.18%3.39M346,100.00%3.46M
Gain on sale of security 14.63%19.7M20.46%6.05M0.59%5.32M16.32%3.96M25.94%4.37M262.14%17.19M88.87%5.02M179.21%5.29M1,702.12%3.41M173,200.00%3.47M
Other non- operating income (expenses) 273,142.50%109.22M322.22%40K40,000.00%1.2M720,033.33%107.99M-150.00%-10K-122.22%-40K30.77%-18K-133.33%-3K---15K-300.00%-4K
Income before tax 53.23%-88.35M-8.68%-59.24M178.34%36.16M93.77%-2.86M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M
Income tax 7.14M6.47M-882K1.55M0000
Net income 49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M
Net income continuous Operations 49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M
Minority interest income
Net income attributable to the parent company 49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M
Basic earnings per share 56.96%-1.02-7.81%-0.69170.37%0.3891.80%-0.05-22.03%-0.72-9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.59
Diluted earnings per share 56.96%-1.02-7.81%-0.69170.37%0.3891.80%-0.05-22.03%-0.72-9.22%-2.37-14.29%-0.64-1.89%-0.54-1.67%-0.61-22.92%-0.59
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
HENDERA
831152
+29.97%
LINGOOD
833284
+29.95%
4
WUHAN LAND
830779
+25.43%
5
TECHVISION
832876
+21.28%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites